Hims & Hers Health Inc’s filing revealed that its Officer Oluyemi Okupe acquired Company’s shares for reported $7.82 million on Sep 15 ’25. In the deal valued at $53.96 per share,145,000 shares were bought.
Then, Chi Michael bought 4,150 shares, generating $232,400 in total proceeds.
Before that, Okupe Oluyemi sold 11,581 shares. Hims & Hers Health Inc shares valued at $505,968 were divested by the Chief Financial Officer at a price of $43.69 per share. As a result of the transaction, Okupe Oluyemi now holds 116,806 shares, worth roughly $6.3 million.
Needham downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early June has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering HIMS and has decreased its forecast on April 29, 2025 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley revised its rating on February 18, 2025. It rated HIMS as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock fall -2.77% to $53.96. Over the last five days, the stock has gained 8.70%. Hims & Hers Health Inc shares have risen nearly 253.37% since the year began. Nevertheless, the stocks have risen 123.16% over the past one year.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2025-08-29, growing by 10.04 million shares to a total of 74.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 64.59 million shares. There was a rise of 13.45%, which implies that there is a positive sentiment for the stock.
